Dionne Price, PhD, BA, MS

Dr. Price provides leadership to statisticians within the Office of Biostatistics in the Center for Drug Evaluation and Research. Her research interests are in the design and analyses of clinical trials. Price has co-authored papers in such journals as Statistics in Medicine, Clinical Trials, and Statistics in Biopharmaceutical Research. She leads cross-cutting, collaborative efforts across FDA to advance and facilitate the use of complex innovative trial designs in pharmaceutical drug development. Price’s effective communication, technical expertise, and keen understanding of regulatory policy have resulted in numerous invitations to represent the FDA on the latest statistical issues as a panel discussant, panel member, or the keynote or invited speaker at national and international conferences.

Price is an active member of the International Biometric Society (IBS) and the American Statistical Association (ASA). She is an ASA Fellow and has been elected as an ASA vice president and president. She will serve a one-year term as president-elect beginning January 1, 2022; her term as president becomes effective January 1, 2023